Unified Global Corp. (CHYL)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Unified Global Corp. (CHYL) trades at $0.46 with AI Score 43/100 (Grade C). Unified Global Corp. operates as a vertically integrated cannabis company in Canada and the United States. Market cap: $27.13M, Sector: Financial services.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for CHYL: CHYL does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CHYL against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
CHYL: the 1 perspectives are evenly split.
How is this calculated? →Unified Global Corp. (CHYL) Financial Services Profile
Unified Global Corp., a vertically integrated cannabis company operating in Canada and the United States, focuses on the cultivation, supply, and retail of hemp/cannabis products. Formerly known as China Senior Living Industry International Holding Corporation, the company is based in Denver, Colorado, navigating a competitive market landscape.
What Is the Investment Thesis for CHYL?
Unified Global Corp. presents a high-risk, high-reward investment opportunity within the cannabis sector. With a market capitalization of $27.13M and a P/E ratio of 44.91, the company's valuation reflects significant growth expectations. A profit margin of 25.2% and a gross margin of 34.6% indicate operational efficiency. Key value drivers include successful expansion of its vertically integrated cannabis operations in Canada and the United States. Upcoming catalysts involve potential regulatory changes in the cannabis industry and expansion into new product lines. However, the company's negative beta of -4.94 suggests high volatility and sensitivity to market fluctuations. Investors should carefully consider the risks associated with investing in a small-cap, OTC-listed company in a highly regulated and competitive industry.
Based on FMP financials and quantitative analysis
CHYL Key Highlights
- Market Cap of $27.13M indicates a small-cap company with potential for growth but also higher risk.
- P/E ratio of 44.91 suggests investors have high expectations for future earnings growth.
- Profit Margin of 25.2% demonstrates the company's ability to generate profit from its revenue.
- Gross Margin of 34.6% reflects the efficiency of the company's production and supply chain operations.
- Beta of -4.94 indicates the stock is significantly less volatile than the market, but may react differently to market movements.
Who Are CHYL's Competitors?
CHYL is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| NSH NavSight Holdings, Inc. | $9.93 | +3.01% | 69 | |
| LRGR Luminar Media Group, Inc. | $0.50 | +47.06% | $22.39M | 68 |
| LMAOU LMF Acquisition Opportunities, Inc. | $12.46 | +41.59% | 68 | |
| APXTW Apex Treasury Corporation | $0.37 | +5.11% | $1.96B | 66 |
| DGNR Dragoneer Growth Opportunities Corp. | $9.26 | +0.00% | $5.79B | 57 |
| KWM K Wave Media Ltd. | $0.15 | -2.40% | $10.04M | 57 |
| IOAC Innovative International Acquisition Corp. | $9.60 | -14.44% | $100.74M | 57 |
| ROCGU Roth CH Acquisition IV Co. | $10.29 | +2.90% | $57.15M | 57 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CHYL's Key Strengths?
- Vertically integrated operations.
- Presence in both Canada and the United States.
- Established supply chain for cannabis products.
What Are CHYL's Weaknesses?
- Small market capitalization.
- Limited brand recognition compared to larger competitors.
- Dependence on regulatory approvals.
What Could Drive CHYL Stock Higher?
- Expansion of cannabis operations in Canada and the United States.
- Potential regulatory changes in the cannabis industry.
- Development and launch of new cannabis-infused products.
- Strategic partnerships and acquisitions to expand market reach.
What Are the Key Risks for CHYL?
- Changes in cannabis regulations impacting operations.
- Intense competition from established cannabis companies.
- Fluctuations in cannabis prices affecting profitability.
- Limited liquidity due to OTC listing.
- Dependence on regulatory approvals for expansion.
What Are the Growth Opportunities for CHYL?
- Expansion into New Product Lines: Unified Global Corp. can explore opportunities to expand its product offerings beyond traditional cannabis products. This could include developing and marketing innovative cannabis-infused beverages, edibles, and wellness products. The market for cannabis-infused products is projected to reach $17 billion by 2027, offering significant growth potential. By diversifying its product portfolio, Unified Global Corp. can attract new customers and increase its market share, mitigating risks associated with relying solely on traditional cannabis products. Timeline: 12-24 months.
- Strategic Partnerships and Acquisitions: Unified Global Corp. can pursue strategic partnerships and acquisitions to expand its market reach and enhance its operational capabilities. Collaborating with established cannabis companies or acquiring smaller, complementary businesses can provide access to new markets, technologies, and distribution channels. The cannabis industry is consolidating, creating opportunities for strategic alliances. By leveraging partnerships and acquisitions, Unified Global Corp. can accelerate its growth and strengthen its competitive position. Timeline: Ongoing.
- Geographic Expansion within North America: Unified Global Corp. can expand its operations into new states and provinces within North America as regulations evolve and new markets open up. Focusing on states with favorable regulatory environments and high growth potential can drive revenue growth and increase market share. The North American cannabis market is projected to reach $47.6 billion by 2025, offering ample opportunities for expansion. By strategically expanding its geographic footprint, Unified Global Corp. can capitalize on the growing demand for cannabis products. Timeline: 24-36 months.
- Development of Proprietary Cannabis Strains: Unified Global Corp. can invest in research and development to develop proprietary cannabis strains with unique characteristics and benefits. This can create a competitive advantage by offering differentiated products that appeal to specific consumer segments. The market for premium and specialty cannabis strains is growing, driven by increasing consumer demand for high-quality products. By developing proprietary strains, Unified Global Corp. can enhance its brand reputation and increase its pricing power. Timeline: 36-48 months.
- Focus on E-commerce and Direct-to-Consumer Sales: Unified Global Corp. can invest in its e-commerce platform and direct-to-consumer sales channels to reach a wider customer base and enhance its brand visibility. The online cannabis market is growing rapidly, driven by increasing consumer adoption of e-commerce and the convenience of online shopping. By focusing on e-commerce, Unified Global Corp. can reduce its reliance on traditional retail channels and improve its profit margins. The global e-commerce market is expected to reach $6.54 trillion in 2023. Timeline: Ongoing.
What Opportunities Does CHYL Have?
- Expansion into new geographic markets.
- Development of innovative cannabis products.
- Strategic partnerships and acquisitions.
What Threats Does CHYL Face?
- Changing regulatory landscape.
- Intense competition from established players.
- Fluctuations in cannabis prices.
What Are CHYL's Competitive Advantages?
- Vertically integrated operations providing cost control.
- Brand recognition in the cannabis market.
- Established distribution network in Canada and the United States.
What Does CHYL Do?
Unified Global Corp., formerly known as China Senior Living Industry International Holding Corporation, transitioned to become a vertically integrated cannabis company. Based in Denver, Colorado, the company focuses on the cultivation, supply, and retail of hemp/cannabis products in both Canada and the United States. This strategic shift reflects an adaptation to evolving market demands and a focus on the burgeoning cannabis industry. Unified Global Corp. aims to control various stages of the cannabis value chain, from cultivation to retail, potentially enhancing profitability and ensuring quality control. The company's operations span across two countries, offering diversification and access to different regulatory environments. As a relatively small player in a rapidly growing sector, Unified Global Corp. faces competition from larger, more established cannabis companies. The company's success hinges on its ability to efficiently manage its operations, navigate regulatory hurdles, and effectively market its products to consumers. With 55 employees, Unified Global Corp. seeks to establish a strong foothold in the cannabis market by leveraging its vertically integrated business model.
What Products and Services Does CHYL Offer?
- Cultivates hemp and cannabis plants.
- Supplies cannabis products to retailers.
- Operates retail outlets for cannabis products.
- Engages in vertically integrated cannabis operations.
- Focuses on the Canadian and United States markets.
- Develops and markets cannabis-related products.
How Does CHYL Make Money?
- Vertically integrated operations from cultivation to retail.
- Revenue generation through the sale of hemp/cannabis products.
- Distribution through retail outlets and supply agreements.
What Industry Does CHYL Operate In?
Unified Global Corp. operates within the rapidly evolving cannabis industry, which is experiencing significant growth and regulatory changes across North America. The market is characterized by increasing competition, technological advancements in cultivation and processing, and evolving consumer preferences. As a vertically integrated company, Unified Global Corp. aims to capture value across the entire cannabis value chain. Competitors include both large, established players and smaller, niche operators. The industry is subject to complex and changing regulations, which can impact market access and profitability. Unified Global Corp.'s success depends on its ability to adapt to these changes and differentiate itself in a crowded market.
Who Are CHYL's Key Customers?
- Recreational cannabis users.
- Medical cannabis patients.
- Retail partners selling cannabis products.
Unified Global Corp. (CHYL) Valuation Context
Valued at $27.13M, CHYL is classified as a micro-cap stock. Relative to its peer group, CHYL's quantitative score of 43/100 is below the peer average of 65/100.
ROE 23%Key Financial Metrics
Return on equity for Unified Global Corp. stands at 22.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 10.6%, showing how much profit it generates from its asset base. CHYL trades at a trailing price-to-earnings ratio of 205.47, above the Financial Services sector average of ~18x. Its free cash flow yield is -0.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.21 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 0.5%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 5/9Financial Health
Unified Global Corp.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 29.19 places it in the safe zone, indicating low near-term bankruptcy risk.
CHYL Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Vertically integrated operations.
- Presence in both Canada and the United States.
- Established supply chain for cannabis products.
- Ongoing: Expansion of cannabis operations in Canada and the United States.
Bear Case
- Small market capitalization.
- Limited brand recognition compared to larger competitors.
- Dependence on regulatory approvals.
- Potential: Changes in cannabis regulations impacting operations.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
CHYL Latest News
No recent news available for CHYL.
CHYL Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CHYL.
Price Targets
Wall Street price target analysis for CHYL.
CHYL MoonshotScore
What does this score mean?
The MoonshotScore rates CHYL's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Shell CompaniesLeadership: Jincao Wu
CEO
Jincao Wu serves as the Chief Executive Officer of Unified Global Corp. His background includes experience in managing and overseeing business operations. While specific details on his prior roles and education are not available, he is responsible for leading the company's strategic direction and day-to-day activities. His leadership is crucial in navigating the evolving cannabis industry and ensuring the company's growth and profitability.
Track Record: As CEO of Unified Global Corp., Jincao Wu is responsible for overseeing the company's transition into a vertically integrated cannabis company. His key achievements include managing the company's operations in both Canada and the United States. Under his leadership, the company focuses on cultivating, supplying, and retailing hemp/cannabis products. His strategic decisions aim to enhance the company's market position and drive revenue growth.
CHYL OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Unified Global Corp. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure.
- Potential for illiquidity.
- Higher risk of fraud or manipulation.
- Lack of regulatory oversight.
- Volatility in stock price.
- Verify the company's financial reporting status.
- Review available financial statements.
- Assess the company's management team and track record.
- Research the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor.
- Company operations in a regulated industry (cannabis).
- Established business operations in Canada and the United States.
- Existence of a management team and employees.
- Company's transition from China Senior Living to cannabis operations.
- Publicly traded status on the OTC market.
Common Questions About CHYL (Financial Services)
What does Unified Global Corp. do?
Unified Global Corp. operates as a vertically integrated cannabis company, focusing on the cultivation, supply, and retail of hemp/cannabis products in both Canada and the United States. The company aims to control the entire value chain, from cultivation to retail distribution, allowing it to manage costs and ensure product quality. This vertical integration strategy positions Unified Global Corp. to capitalize on the growing demand for cannabis products in North America. The company's operations span across multiple states and provinces, providing diversification and access to different regulatory environments. Unified Global Corp. seeks to establish a strong foothold in the cannabis market by leveraging its integrated business model and focusing on quality and innovation.
What do analysts say about CHYL stock?
As of 2026-03-17, there is no available analyst coverage for Unified Global Corp. (CHYL). Given its small market capitalization of $27.13M and OTC listing, the company may not attract significant analyst attention. Investors should conduct their own due diligence and carefully evaluate the company's financial performance, growth prospects, and risk factors before making investment decisions. Key valuation metrics to consider include the company's P/E ratio of 44.91, profit margin of 25.2%, and gross margin of 34.6%. Growth considerations include the company's ability to expand its operations, develop new products, and navigate the evolving regulatory landscape.
What are the main risks for CHYL?
Unified Global Corp. faces several risks inherent to its operations and industry. One significant risk is the evolving regulatory landscape for cannabis in Canada and the United States, where changes in regulations can impact the company's ability to operate and expand. Intense competition from larger, more established cannabis companies poses another challenge. Fluctuations in cannabis prices can affect profitability, and the company's small market capitalization and OTC listing contribute to limited liquidity. Dependence on regulatory approvals for expansion and potential changes in consumer preferences also present risks. Investors should carefully consider these factors before investing in CHYL.
How is Unified Global Corp. adapting to regulatory changes in the cannabis industry?
Unified Global Corp. is adapting to regulatory changes in the cannabis industry by closely monitoring legislative developments and engaging with regulatory bodies. The company is focusing on maintaining compliance with existing regulations and proactively preparing for potential changes. Strategies include diversifying its operations across different states and provinces with varying regulatory environments, investing in compliance infrastructure, and developing contingency plans to mitigate the impact of adverse regulatory changes. Unified Global Corp. also seeks to influence regulatory outcomes through industry advocacy and participation in policy discussions. This proactive approach aims to ensure the company can navigate the evolving regulatory landscape and maintain its competitive position.
What are Unified Global Corp.'s capital requirements and how are they being met?
Unified Global Corp.'s capital requirements primarily relate to funding its cannabis cultivation, supply, and retail operations, as well as supporting its expansion plans. The company's capital needs include investments in infrastructure, equipment, inventory, and marketing. Given its small market capitalization and OTC listing, Unified Global Corp. may face challenges in accessing traditional sources of capital, such as bank loans or equity offerings. The company may rely on alternative financing sources, such as private placements, debt financing, or revenue from operations. Investors should carefully assess the company's financial position and its ability to meet its capital requirements to support its growth strategy. Details on specific financing arrangements are not available.
What are the key factors to evaluate for CHYL?
Unified Global Corp. (CHYL) holds an AI score of 43/100 (low). Not financial advice.
How frequently does CHYL data refresh on this page?
CHYL prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven CHYL's recent stock price performance?
Unified Global Corp. (CHYL) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Vertically integrated operations. See the News tab for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be limited due to the company's OTC listing and limited analyst coverage.
- AI analysis pending for CHYL, which may provide further insights.